These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29036037)

  • 1. Recent developments in systemic therapy for hepatocellular carcinoma.
    Zhu AX
    Clin Adv Hematol Oncol; 2017 Aug; 15 Suppl 9(8):7-13. PubMed ID: 29036037
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
    Yau T; Pang R; Chan P; Poon RT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].
    Burtin P
    Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma.
    Kambadakone A; Baliyan V; Zhu AX
    Semin Liver Dis; 2017 Aug; 37(3):259-274. PubMed ID: 28847036
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant interferon for hepatocellular carcinoma.
    Okada S; Sato T; Yamamoto S
    Hepatology; 2001 Feb; 33(2):481-2. PubMed ID: 11172357
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for highly advanced hepatocellular carcinoma.
    Tanikawa K
    J Gastroenterol Hepatol; 2001 Apr; 16(4):361-2. PubMed ID: 11354272
    [No Abstract]   [Full Text] [Related]  

  • 8. Need of stratifying patients according to severity of underlying liver disease for hepatocellular carcinoma patients undergoing systemic therapy trials.
    Yeo W; Mo FK; Hui P; Chan SL
    Contemp Clin Trials; 2010 Mar; 31(2):135. PubMed ID: 20123038
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced hepatocellular carcinoma.
    Tanikawa K; Tanaka M
    Intern Med; 1995 Apr; 34(4):300-2. PubMed ID: 7606108
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.
    Azmi AN; Chan WK; Goh KL
    J Dig Dis; 2015 Sep; 16(9):537-40. PubMed ID: 26147446
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of multiple targeted agents as potential therapies for hepatocellular carcinoma (HCC). Foreword.
    Kummar S
    Curr Probl Cancer; 2010; 34(2):130. PubMed ID: 20417352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC; Wang L; Wu WZ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatocellular carcinoma management in the era of sorafenib].
    Rosmorduc O
    Gastroenterol Clin Biol; 2009 Apr; 33(4):327-33. PubMed ID: 19321281
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of inoperable cancers of the exocrine pancreas and liver].
    Knuth A
    Z Gastroenterol Verh; 1991 Mar; 26():219. PubMed ID: 1714154
    [No Abstract]   [Full Text] [Related]  

  • 16. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
    Facciorusso A; Licinio R; Carr BI; Di Leo A; Barone M
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):993-1003. PubMed ID: 25915713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced hepatocellular carcinoma: beyond sorafenib.
    Meyer T
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):218-220. PubMed ID: 29533189
    [No Abstract]   [Full Text] [Related]  

  • 18. Current problems with systemic treatment of advanced hepatocellular cancer.
    He AR; Soe K; El Zouhairi M
    Curr Probl Cancer; 2010; 34(2):131-49. PubMed ID: 20417353
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.